- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02336867
Therapeutic Management of Complex Anal Fistulas by Installing a Closure Clip: Multicentre Randomized Controlled Trial (FISCLOSE)
Anal fistulas are the main etiology of perianal abscesses and suppurations. They are common and generally associated with pain, anal incontinence, impaired quality of life and work incapacity. The therapeutic management of this disease has a double objective: heal the suppuration and preserve the sphincter function. Each year, anal fistulas affect 1 in 10 000 in the normal population, with a difference in prevalence between men and women (1.23 per 10 000 men and 0.56 per 10 000 women). The average age of the patients was 40 years (Simpson et al., 2012).
In about 80% of cases, anal fistulas are secondary to an infection of Hermann and Desfosses' anal glands (cryptogenic or cryptoglandular). Infection of the anal gland can result in an abscess between the internal and external sphincters, which in turn can spread to other parts of the perianal region. The infection can follow many directions from this point in the intersphincteric plan. When the pus reaches the skin, the fistula is formed. Anal fistula therefore has always an intraductal origin, cryptic, with a primary port at this level, and the disregard of which causes the recurrence of the fistula; and usually a secondary port in the skin.
Fistulas are usually divided into two groups. The first group contains fistulas called "simple", which are intersphincteric fistulas or trans-sphincteric involving only the lower third of the sphincter complex. Fistulas usually didn't affect any muscle. The second group contains fistulas called "complex". These are intersphincteric, trans-sphincteric, or even suprasphincteric, extrasphincteric fistulas.
For many years, the treatment of choice was to open the fistula (fistulotomy), but this procedure was associated with a risk of incontinence, the consequences could be potentially devastating. Other surgical treatments include setons, fibrin glue, collagen plugs and advancement flap technique to cover internal opening of the fistula. The success of these therapies remains variable.
The advancement flap technique remains a strategy of choice in the treatment of anal fistulas and particularly in the case of complex fistulas. The success rate of the advancement flap technique remains variable across studies but a recent meta-analysis finds a success rate of around 60%.
A new technique for closing anal fistula is currently in development with the use of a closure clip nitinol (OTSC® Proctology Laboratory: OVESCO and French Distributor: Life Partners). This new technique has been validated in a porcine model of anal fistula, ensuring the safety of the device. A first case was published in a patient with complex anal fistula (high trans-sphincteric). After erosion fistula tract with a special brush, a nitinol clip (OTSC® Proctology) was deposited on the internal opening of the fistula. Eight months after surgery, the fistula was healed and the clip was removed by cutting with special pliers. This technique is currently being broadcast and dozens of patients were treated with this clip without any further scientific validation of the process.
To date, this innovative technique of the closure clip has not yet been assessed in a randomized controlled trial. It is therefore essential to carry out a prospective evaluation in order to determine the effectiveness and safety of this new device in the case of complex anal fistulas.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After validation of the inclusion and exclusion criteria, the patients included in this clinical trial will be randomized between the two arms of the study for the closure of the anal fistula:
- Control group: advancement flap technique Experimental group: closure clip (OTSC® Proctology Laboratory: OVESCO and French Distributor: Life Partners)
Follow up of the patients will be performed until 1 year after the intervention.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Recruiting
- CHU de Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Complex anal fistula (intersphincteric, trans-sphincteric, or even suprasphincteric, extrasphincteric) drained and requiring closing intervention of fistula.
- Obtaining the patient's written consent
- Naive patient to any surgical treatment for fistula closure
- Patient receiving a social security scheme
Exclusion Criteria:
- <18 years and> 80 years
- BMI> 35 kg / m²
- Rectovaginal or rectourethral fistulas
- Infections : sepsis, tuberculosis or HIV
- History of allergy to nickel
- Cognitive disorders or major disability making it impossible to understand the study and signed an informed consent
- Already included in another clinical trial patients
- breastfeeding or pregnancy
- Legal incapacity (person deprived of liberty or guardianship)
- Patients not compliant with the criteria of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
closure clip (OTSC® Proctology Laboratory: OVESCO and French Distributor: Life Partners)
|
|
Other: Control group
advancement flap technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of patients with healed anal fistula
Time Frame: at 3 months after surgery
|
The diagnosis will be made by the lack of leakage alleged by the patient for at least one month and found on clinical examination
|
at 3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Anal fistula healing
Time Frame: at 6 months and 1 year
|
at 6 months and 1 year
|
VAS proctologic pain
Time Frame: days 0, 1, 2, 3, 15, 30, 60, 90, 180 and 365
|
days 0, 1, 2, 3, 15, 30, 60, 90, 180 and 365
|
Anal incontinence score (questionnaire Jorge and Wexner)
Time Frame: days 0, 15, 30, 60, 90, 180 and 365
|
days 0, 15, 30, 60, 90, 180 and 365
|
Digestive disorders and quality of life (GIQLI questionnaire)
Time Frame: days 0, 15, 30, 60, 90, 180 and 365
|
days 0, 15, 30, 60, 90, 180 and 365
|
Quality of life (EQ5D Questionnaire)
Time Frame: days 0, 30, 90, 365
|
days 0, 30, 90, 365
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anne DUBOIS, University Hospital, Clermont-Ferrand
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-2018
- 2014-A00441-46 (Registry Identifier: 2014-A00441-46)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complex Anal Fistula
-
F Care Systems NVNot yet recruiting
-
Dr Benjamin NEBBOTSuspended
-
Groupe Hospitalier Paris Saint JosephCompletedComplex Anal FistulaFrance
-
China-Japan Friendship HospitalCompletedHigh Complex Anal FistulaChina
-
University Hospital, Basel, SwitzerlandUnity Health Toronto; Mount Sinai Hospital, Canada; Women's College Hospital; St...CompletedComplex Anal FistulaSwitzerland
-
Zagazig UniversityCompletedTranssphincteric Anal FistulaEgypt
-
Chinese University of Hong KongTerminated
-
Societa Italiana di Chirurgia ColoRettaleTerminated
-
Mansoura UniversityUnknownVideo Assisted Anal Fistula TreatmentEgypt
-
Assiut UniversityActive, not recruiting
Clinical Trials on Closure clip (OTSC® Proctology)
-
Asian Institute of Gastroenterology, IndiaOvesco Endoscopy AGNot yet recruiting
-
Azienda USL ModenaRecruiting
-
Renmin Hospital of Wuhan UniversityNot yet recruitingColorectal Polyp | Post-polypectomy BleedingChina
-
Chinese University of Hong KongCompletedUlcer Bleeding | Upper Gastrointestinal Tract BleedingHong Kong
-
Ankara UniversityActive, not recruiting
-
White River Junction Veterans Affairs Medical CenterDartmouth College; Boston Scientific CorporationActive, not recruitingColon PolypsUnited States
-
CURE Digestive Diseases Research CenterUniversity of California, Los Angeles; VA Greater Los Angeles Healthcare SystemRecruitingUpper Gastrointestinal HemorrhageUnited States
-
Kliniken Essen-MitteRecruitingPrimary Breast CancerGermany
-
Meir Medical CenterCompletedAll Appendectomies Performed During the Designated Period in Single Medical CenterIsrael
-
Fundacion Miguel ServetCompletedHaemorrhage | Endoscopic Resection | Clip | Non-pedunculated LesionsSpain